New chemical adaptor unit designed to release a drug from a tumor targeting device by enzymatic triggering

  • Anna Gopin
  • , Christoph Rader
  • , Doron Shabat*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

A new controlled drug delivery system for selective chemotherapy was developed. It is based on a chemical adaptor unit, that releases a drug by a spontaneous cyclization mechanism after cleavage of an enzymatic substrate. It also provides a generic linkage of a drug with a targeting device in a manner set to be triggered by defined enzymatic activity. The system is generic and allows using a variety of drugs, targeting devices, and enzymes by introducing the corresponding substrate as a trigger for drug release in the chemical adaptor.

Original languageEnglish
Pages (from-to)1853-1858
Number of pages6
JournalBioorganic and Medicinal Chemistry
Volume12
Issue number8
DOIs
StatePublished - 15 Apr 2004

Keywords

  • 1-[3-(dimethylamino)propyl]-3- ethylcarbodiimide
  • 9-fluorenylmethoxycarbonyl
  • Boc-t-buthyl carbonate
  • DIPEA
  • DMAP
  • DMF
  • Diisopropyl ethyl amine
  • Dimethyl aminopyridine
  • Dimethyl formamide
  • EDC
  • EtN
  • EtOAc
  • Ethyl acetate
  • Fmoc
  • He
  • N-Hexane
  • Triethyl amine

Fingerprint

Dive into the research topics of 'New chemical adaptor unit designed to release a drug from a tumor targeting device by enzymatic triggering'. Together they form a unique fingerprint.

Cite this